NEW: Vector genomics fellows... more
1195 Tracking Artemisinin Resistance Collaboration (TRAC II)

Partner study description

A multi-centre, open-label randomized trial to assess the efficacy, safety and tolerability of Triple Artemisinin-based Combination Therapies (TACTs) compared to Artemisinin-based Combination Therapies (ACTs) in uncomplicated falciparum malaria and to map the geographical spread of artemisinin and partner drug resistance. Samples submitted in this study are extracted Plasmodium falciparum DNA.